# Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

Study · id `cardio:ct-nct04922281` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04922281](<https://clinicaltrials.gov/study/NCT04922281>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04922281

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04922281. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-28 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04922281, source copy `cardio:ctgov-nct04922281-2025-10-14`, retrieved 2026-10-26)
- Started: 2022-02-28 (actual) (ClinicalTrials.gov record NCT04922281, source copy `cardio:ctgov-nct04922281-2025-10-14`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT04922281, source copy `cardio:ctgov-nct04922281-2025-10-14`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT04922281, source copy `cardio:ctgov-nct04922281-2025-10-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04922281, source copy `cardio:ctgov-nct04922281-2025-10-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04922281-2025-10-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
- Acronym: ICMREDUCE-AF
- Condition: Atrial Fibrillation
- Condition: Cardiovascular Diseases
- Condition: Heart Diseases
- Condition: Arrhythmias, Cardiac
- Condition: Pathologic Processes
- Intervention (Device): Insertable Cardiac Monitor or external non-invasive LT-ECG patch
- Lead sponsor: University of Rochester
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University of Rochester (`cardio:org-university-of-rochester`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 2015bec3eed04da66558d0c15e1c02ea930bb663af7bee537e90ae8debe77e21
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
